MicroRNA: Biogenesis, function and role in cancer

Current Genomics

Volumn 11, Issue 7, 2010, Pages 537-561

  MacFarlane, Leigh Ann ^a   Murphy, Paul R ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cancer; MicroRNA; Post transcriptional gene regulation; RNA interference (RNAi)

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; MESSENGER RNA; MICRORNA; RNA INDUCED SILENCING COMPLEX; RNA POLYMERASE II; UNTRANSLATED RNA;

ARTICLE; CARCINOGENESIS; CYTOPLASM; GENE EXPRESSION; GENE SILENCING; GENOME; HUMAN; LET 7 ONCOGENE; NONHUMAN; NUCLEAR EXPORT SIGNAL; ONCOGENE; RNA PROCESSING; RNA TRANSCRIPTION; THERMODYNAMICS; TUMOR SUPPRESSOR GENE;

EID: 78650004201     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920210793175895     Document Type: Article

References (381)

1. Perron, M. P.; Provost, P. Protein interactions and complexes in human microRNA biogenesis and function. Front. Biosci., 2008, 13, 2537-2547.
2. Wightman, B. H. I.; Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediated temporal pattern formation in C. elegans. Cell, 1993, 75, 855-862.
3. Lee, R.C. F. R.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75, 843-854.
4. Rajewsky, N. L(ou)sy miRNA targets? Nat. Struct. Mol. Biol. 2006, 13, 754-755.
5. Rajewsky, N. microRNA target predictions in animals. Nat. Genet., 2006, 38(Suppl), S8-13.
6. Liu, W.; Mao, S. Y.; Zhu, W. Y. Impact of tiny miRNAs on cancers. World J. Gastroenterol., 2007, 13, 497-502.
7. Berezikov, E.; Guryev, V.; van de Belt, J.; Wienholds, E.; Plasterk, R. H.; Cuppen, E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell, 2005, 120, 21-24.
8. Stanczyk, J.; Pedrioli, D. M.; Brentano, F.; Sanchez-Pernaute, O.; Kolling, C.; Gay, R. E.; Detmar, M.; Gay, S.; Kyburz, D. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum., 2008, 58, 1001-1009.
9. Griffiths-Jones, S. miRBase: the microRNA sequence database. Methods Mol. Biol., 2006, 342, 129-138.
10. Griffiths-Jones, S. The microRNA Registry. Nucleic Acids Res., 2004, 32, D109-111.
11. Griffiths-Jones, S.; Saini, H. K.; van Dongen, S.; Enright, A. J. miRBase: tools for microRNA genomics. Nucleic Acids Res., 2008, 36, D154-158.
12. Cullen, B. R. Transcription and processing of human microRNA precursors. Mol. Cell, 2004, 16, 861-865.
13. Esau, C.; Davis, S.; Murray, S. F.; Yu, X. X.; Pandey, S. K.; Pear, M.; Watts, L.; Booten, S. L.; Graham, M.; McKay, R.; Subramaniam, A.; Propp, S.; Lollo, B. A.; Freier, S.; Bennett, C. F.; Bhanot, S.; Monia, B. P. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab., 2006, 3, 87-98.
14. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature, 2005, 438, 685-689.
15. Zhao, Y.; Samal, E.; Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 2005, 436, 214-220.
16. Naguibneva, I.; Ameyar-Zazoua, M.; Polesskaya, A.; Ait-Si-Ali, S.; Groisman, R.; Souidi, M.; Cuvellier, S.; Harel-Bellan, A. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat. Cell Biol., 2006, 8, 278-284.
17. Garzon, R.; Pichiorri, F.; Palumbo, T.; Iuliano, R.; Cimmino, A.; Aqeilan, R.; Volinia, S.; Bhatt, D.; Alder, H.; Marcucci, G.; Calin, G. A.; Liu, C. G.; Bloomfield, C. D.; Andreeff, M.; Croce, C. M. MicroRNA fingerprints during human megakaryocytopoiesis. Proc. Natl. Acad. Sci. USA, 2006, 103, 5078-5083.
18. Monticelli, S.; Ansel, K. M.; Xiao, C.; Socci, N. D.; Krichevsky, A. M.; Thai, T. H.; Rajewsky, N.; Marks, D. S.; Sander, C.; Rajewsky, K.; Rao, A.; Kosik, K. S. MicroRNA profiling of the murine hematopoietic system. Genome Biol., 2005, 6, R71.
19. Ambros, V. The functions of animal microRNAs. Nature, 2004, 431, 350-355.
20. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116, 281-297.
21. Mayr, C.; Hemann, M. T.; Bartel, D. P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science, 2007, 315(5818), 1576-9.
22. Lee, Y. S.; Dutta, A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev., 2007, 21, 1025-1030.
23. Wang, T.; Zhang, X.; Obijuru, L.; Laser, J.; Aris, V.; Lee, P.; Mittal, K.; Soteropoulos, P.; Wei, J. J. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer, 2007, 46, 336-347.
24. Garzon, R.; Fabbri, M.; Cimmino, A.; Calin, G. A.; Croce, C. M. MicroRNA expression and function in cancer. Trends Mol. Med., 2006, 12, 580-587.
25. Nelson, P. T.; Wang, W. X.; Rajeev, B. W. MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol., 2008, 18, 130-138.
26. Wang, W. X.; Rajeev, B. W.; Stromberg, A. J.; Ren, N.; Tang, G.; Huang, Q.; Rigoutsos, I.; Nelson, P. T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci., 2008, 28, 1213-1223.
27. Hansen, T.; Olsen, L.; Lindow, M.; Jakobsen, K. D.; Ullum, H.; Jonsson, E.; Andreassen, O. A.; Djurovic, S.; Melle, I.; Agartz, I.; Hall, H.; Timm, S.; Wang, A. G.; Werge, T. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE, 2007, 2, e873.
28. Jay, C.; Nemunaitis, J.; Chen, P.; Fulgham, P.; Tong, A. W. MiRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol., 2007, 26, 293-300.
29. Hernando, E. MicroRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin. Transl. Oncol., 2007, 9, 155-160.
30. Barbarotto, E.; Schmittgen, T. D.; Calin, G. A. MicroRNAs and cancer: profile, profile, profile. Int. J. Cancer, 2008, 122, 969-977.
31. Lu, J.; Getz, G.; Miska, E. A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B. L.; Mak, R. H.; Ferrando, A. A.; Downing, J. R.; Jacks, T.; Horvitz, H. R.; Golub, T. R. MicroRNA expression profiles classify human cancers. Nature, 2005, 435, 834-838.
32. Ambros, V.; Bartel, B.; Bartel, D. P.; Burge, C. B.; Carrington, J. C.; Chen, X.; Dreyfuss, G.; Eddy, S. R.; Griffiths-Jones, S.; Marshall, M.; Matzke, M.; Ruvkun, G.; Tuschl, T. A uniform system for microRNA annotation. Rna, 2003, 9, 277-279.
33. Kim, V. N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell. Biol., 2005, 6, 376-385.
34. Kim, V. N. Small RNAs: classification, biogenesis, and function. Mol. Cells, 2005, 19, 1-15.
35. Lagos-Quintana, M.; Rauhut, R.; Meyer, J.; Borkhardt, A.; Tuschl, T. New microRNAs from mouse and human. RNA, 2003, 9, 175-179.
36. Rodriguez, A.; Griffiths-Jones, S.; Ashurst, J. L.; Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res., 2004, 14, 1902-1910.
37. Ying, S. Y.; Chang, C. P.; Lin, S. L. Intron-mediated RNA interference, intronic microRNAs, and applications. Methods Mol. Biol., 2010, 629, 205-237.
38. Saini, H. K.; Griffiths-Jones, S. Enright, A. J. Genomic analysis of human microRNA transcripts. Proc. Natl. Acad. Sci. USA, 2007, 104, 17719-17724.
39. Altuvia, Y.; Landgraf, P.; Lithwick, G.; Elefant, N.; Pfeffer, S.; Aravin, A.; Brownstein, M. J.; Tuschl, T.; Margalit, H. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res., 2005, 33, 2697-2706.
40. Yu, J.; Wang, F.; Yang, G. H.; Wang, F. L.; Ma, Y. N.; Du, Z. W.; Zhang, J. W. Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem. Biophys. Res. Commun., 2006, 349, 59-68.
41. Cullen, B. R. Derivation and function of small interfering RNAs and microRNAs. Virus Res., 2004, 102, 3-9.
42. Lee, Y.; Kim, M.; Han, J.; Yeom, K. H.; Lee, S.; Baek, S. H.; Kim, V. N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J., 2004, 23, 4051-4060.
43. Cai, X.; Hagedorn, C. H.; Cullen, B. R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 2004, 10, 1957-1966.
44. Bartel, D. P.; Chen, C. Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet., 2004, 5, 396-400.
45. Cramer, P. Structure and function of RNA polymerase II. Adv. Protein Chem., 2004, 67, 1-42.
46. Ohkuma, Y. [Function and structural biology of general transcription factors and RNA polymerase II in eukaryotes]. Tanpakushitsu Kakusan Koso, 1999, 44, 438-456.
47. Woychik, N. A.; Young, R. A. RNA polymerase II: subunit structure and function. Trends Biochem. Sci., 1990, 15, 347-351.
48. Goodfellow, S. J.; White, R. J. Regulation of RNA polymerase III transcription during mammalian cell growth. Cell Cycle, 2007, 6, 2323-2326.
49. Felton-Edkins, Z. A.; Kenneth, N. S.; Brown, T. R.; Daly, N. L.; Gomez-Roman, N.; Grandori, C.; Eisenman, R. N.; White, R. J. Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc. Cell Cycle, 2003, 2, 181-184.
50. Scott, P. H.; Cairns, C. A.; Sutcliffe, J. E.; Alzuherri, H. M.; McLees, A.; Winter, A. G.; White, R. J. Regulation of RNA polymerase III transcription during cell cycle entry. J. Biol. Chem., 2001, 276, 1005-1014.
51. White, R. J.; Gottlieb, T. M.; Downes, C. S.; Jackson, S. P. Cell cycle regulation of RNA polymerase III transcription. Mol. Cell Biol., 1995, 15, 6653-6662.
52. Costanzo, G.; Camier, S.; Carlucci, P.; Burderi, L.; Negri, R. RNA polymerase III transcription complexes on chromosomal 5S rRNA genes in vivo: TFIIIB occupancy and promoter opening. Mol. Cell Biol., 2001, 21, 3166-3178.
53. Young, L. S.; Rivier, D. H.; Sprague, K. U. Sequences far downstream from the classical tRNA promoter elements bind RNA polymerase III transcription factors. Mol. Cell Biol., 1991, 11, 1382-1392.
54. Besser, D.; Gotz, F.; Schulze-Forster, K.; Wagner, H.; Kroger, H.; Simon, D. DNA methylation inhibits transcription by RNA polymerase III of a tRNA gene, but not of a 5S rRNA gene. FEBS Lett., 1990, 269, 358-362.
55. Kassavetis, G. A.; Riggs, D. L.; Negri, R.; Nguyen, L. H.; Geiduschek, E. P. Transcription factor IIIB generates extended DNA interactions in RNA polymerase III transcription complexes on tRNA genes. Mol. Cell Biol., 1989, 9, 2551-2566.
56. Chen, C. Z.; Li, L.; Lodish, H. F.; Bartel, D. P. MicroRNAs modulate hematopoietic lineage differentiation. Science, 2004, 303, 83-86.
57. Borchert, G. M.; Lanier, W.; Davidson, B. L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol., 2006, 13, 1097-1101.
58. Hess, J.; Perez-Stable, C.; Wu, G. J.; Weir, B.; Tinoco, I., Jr. Shen, C. K. End-to-end transcription of an Alu family repeat. A new type of polymerase-III-dependent terminator and its evolutionary implication. J. Mol. Biol., 1985, 184, 7-21.
59. Gu, T. J.; Yi, X.; Zhao, X. W.; Zhao, Y.; Yin, J. Q. Alu-directed transcriptional regulation of some novel miRNAs. BMC Genomics, 2009, 10, 563.
60. Ambros, V.; Lee, R. C. Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol. Biol., 2004, 265, 131-158.
61. Pillai, R. S.; Bhattacharyya, S. N.; Filipowicz, W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol., 2007, 17, 118-126.
62. Miranda, K. C.; Huynh, T.; Tay, Y.; Ang, Y. S.; Tam, W. L.; Thomson, A. M.; Lim, B.; Rigoutsos, I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell, 2006, 126, 1203-1217.
63. Davis, C. D.; Ross, S. A. Evidence for dietary regulation of microRNA expression in cancer cells. Nutr. Rev., 2008, 66, 477-482.
64. Fiedler, S. D.; Carletti, M. Z.; Hong, X.; Christenson, L. K. Hormonal regulation of microRNA expression in periovulatory mouse mural granulosa cells. Biol. Reprod., 2008, 79(6), 1030-7.
65. Kulshreshtha, R.; Ferracin, M.; Negrini, M.; Calin, G. A.; Davuluri, R. V.; Ivan, M. Regulation of microRNA expression: the hypoxic component. Cell Cycle, 2007, 6, 1426-1431.
66. Kulshreshtha, R.; Ferracin, M.; Wojcik, S. E.; Garzon, R.; Alder, H.; Agosto-Perez, F. J.; Davuluri, R.; Liu, C. G.; Croce, C. M.; Negrini, M.; Calin, G. A.; Ivan, M. A microRNA signature of hypoxia. Mol. Cell. Biol., 2007, 27, 1859-1867.
67. O'Donnell, K. A.; Wentzel, E. A.; Zeller, K. I.; Dang, C. V.; Mendell, J. T. C-Myc-regulated microRNAs modulate E2F1 expression. Nature, 2005, 435, 839-843.
68. Sylvestre, Y.; De Guire, V.; Querido, E.; Mukhopadhyay, U. K.; Bourdeau, V.; Major, F.; Ferbeyre, G.; Chartrand, P. An E2F/miR- 20a autoregulatory feedback loop. J. Biol. Chem., 2007, 282, 2135-2143.
69. Woods, K.; Thomson, J. M.; Hammond, S. M. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J. Biol. Chem., 2007, 282, 2130-2134.
70. Davis, B. N.; Hilyard, A. C.; Nguyen, P. H.; Lagna, G.; Hata, A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell, 2010, 39, 373-384.
71. Michlewski, G.; Guil, S.; Semple, C. A.; Caceres, J. F. Posttranscriptional regulation of miRNAs harboring conserved terminal loops. Mol. Cell., 2008, 32, 383-393.
72. Viswanathan, S. R.; Daley, G. Q. Lin28: A microRNA regulator with a macro role. Cell, 2010, 140, 445-449.
73. Han, L.; Witmer, P. D.; Casey, E.; Valle, D.; Sukumar, S. DNA Methylation Regulates MicroRNA Expression. Cancer Biol. Ther., 2007, 6, 1284-8.
74. Yu, Z.; Wang, C.; Wang, M.; Li, Z.; Casimiro, M. C.; Liu, M.; Wu, K.; Whittle, J.; Ju, X.; Hyslop, T.; McCue, P.; Pestell, R. G. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol., 2008, 182, 509-517.
75. Denli, A. M.; Tops, B. B.; Plasterk, R. H.; Ketting, R. F.; Hannon, G. J. Processing of primary microRNAs by the Microprocessor complex. Nature, 2004, 432, 231-235.
76. Du, T.; Zamore, P. D. microPrimer: the biogenesis and function of microRNA. Development, 2005, 132, 4645-4652.
77. Gregory, R. I.; Yan, K. P.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N.; Shiekhattar, R. The Microprocessor complex mediates the genesis of microRNAs. Nature, 2004, 432, 235-240.
78. Han, J.; Lee, Y.; Yeom, K. H.; Kim, Y. K.; Jin, H.; Kim, V. N. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev., 2004, 18, 3016-3027.
79. Hutvagner, G.; McLachlan, J.; Pasquinelli, A. E.; Balint, E.; Tuschl, T.; Zamore, P. D. A cellular function for the RNAinterference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science, 2001, 293, 834-838.
80. Lee, Y.; Ahn, C.; Han, J.; Choi, H.; Kim, J.; Yim, J.; Lee, J.; Provost, P.; Radmark, O.; Kim, S.; Kim, V. N. The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003, 425, 415-419.
81. Lee, Y.; Jeon, K.; Lee, J. T.; Kim, S.; Kim, V. N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J., 2002, 21, 4663-4670.
82. Lin, S. L.; Kim, H.; Ying, S. Y. Intron-mediated RNA interference and microRNA (miRNA). Front. Biosci., 2008, 13, 2216-2230.
83. Han, J.; Lee, Y.; Yeom, K. H.; Nam, J. W.; Heo, I.; Rhee, J. K.; Sohn, S. Y.; Cho, Y.; Zhang, B. T.; Kim, V. N. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell, 2006, 125, 887-901.
84. Abbott, A. L.; Alvarez-Saavedra, E.; Miska, E. A.; Lau, N. C.; Bartel, D. P.; Horvitz, H. R.; Ambros, V. The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev. Cell, 2005, 9, 403-414.
85. Zeng, Y.; Cai, X.; Cullen, B. R. Use of RNA polymerase II to transcribe artificial microRNAs. Methods Enzymol., 2005, 392, 371-380.
86. Zeng, Y.; Cullen, B. R. Sequence requirements for micro RNA processing and function in human cells. RNA, 2003, 9, 112-123.
87. Zeng, Y.; Cullen, B. R. Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences. J. Biol. Chem., 2005, 280, 27595-27603.
88. Zhang, X.; Zeng, Y. The terminal loop region controls microRNA processing by Drosha and Dicer. Nucleic Acids Res., 2010, [Epub ahead of print].
89. Han, J.; Pedersen, J. S.; Kwon, S. C.; Belair, C. D.; Kim, Y. K.; Yeom, K. H.; Yang, W. Y.; Haussler, D.; Blelloch, R.; Kim, V. N. Posttranscriptional crossregulation between Drosha and DGCR8. Cell, 2009, 136, 75-84.
90. Triboulet, R.; Chang, H. M.; Lapierre, R. J.; Gregory, R. I. Posttranscriptional control of DGCR8 expression by the Microprocessor. RNA, 2009, 15, 1005-1011.
91. Guil, S.; Caceres, J. F. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat. Struct. Mol. Biol., 2007, 14, 591-596.
92. Gregory, R. I.; Shiekhattar, R. MicroRNA biogenesis and cancer. Cancer Res., 2005, 65, 3509-3512.
93. Zeng, Y.; Yi, R.; Cullen, B. R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. USA, 2003, 100, 9779-9784.
94. Kim, Y. K.; Kim, V. N. Processing of intronic microRNAs. EMBO J., 2007, 26, 775-783.
95. Ying, S. Y.; Lin, S. L. Intron-derived microRNAs--fine tuning of gene functions. Gene, 2004, 342, 25-28.
96. Lin, S. L.; Chang, D.; Wu, D. Y.; Ying, S. Y. A novel RNA splicing- mediated gene silencing mechanism potential for genome evolution. Biochem. Biophys. Res. Commun., 2003, 310, 754-760.
97. Berezikov, E.; Chung, W. J.; Willis, J.; Cuppen, E.; Lai, E. C. Mammalian mirtron genes. Mol. Cell, 2007, 28, 328-336.
98. Rainer, J.; Ploner, C.; Jesacher, S.; Ploner, A.; Eduardoff, M.; Mansha, M.; Wasim, M.; Panzer-Grumayer, R.; Trajanoski, Z.; Niederegger, H.; Kofler, R. Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia, 2009, 23, 746-752.
99. Ruby, J. G.; Jan, C. H.; Bartel, D. P. Intronic microRNA precursors that bypass Drosha processing. Nature, 2007, 448, 83-86.
100. Lin, S. L.; Miller, J. D.; Ying, S. Y. Intronic MicroRNA (miRNA). J. Biomed. Biotechnol., 2006, 2006, 26818.
101. Bohnsack, M. T.; Czaplinski, K.; Gorlich, D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA, 2004, 10, 185-191.
102. Lund, E.; Dahlberg, J. E. Substrate Selectivity of Exportin 5 and Dicer in the Biogenesis of MicroRNAs. Cold Spring Harb. Symp. Quant. Biol., 2006, 71, 59-66.
103. Okada, C.; Yamashita, E.; Lee, S. J.; Shibata, S.; Katahira, J.; Nakagawa, A.; Yoneda, Y.; Tsukihara, T. A high-resolution structure of the pre-microRNA nuclear export machinery. Science, 2009, 326, 1275-1279.
104. Yi, R.; Qin, Y.; Macara, I. G.; Cullen, B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev., 2003, 17, 3011-3016.
105. Zeng, Y.; Cullen, B. R. Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Res., 2004, 32, 4776-4785.
106. Okamura, K.; Hagen, J. W.; Duan, H.; Tyler, D. M.; Lai, E. C. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell, 2007, 130, 89-100.
107. Zhang, H.; Kolb, F. A.; Brondani, V.; Billy, E.; Filipowicz, W. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J., 2002, 21, 5875-5885.
108. Filipowicz, W.; Jaskiewicz, L.; Kolb, F. A.; Pillai, R. S. Posttranscriptional gene silencing by siRNAs and miRNAs. Curr. Opin. Struct. Biol., 2005, 15, 331-341.
109. Haase, A. D.; Jaskiewicz, L.; Zhang, H.; Laine, S.; Sack, R.; Gatignol, A.; Filipowicz, W. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep., 2005, 6, 961-967.
110. Jiang, F.; Ye, X.; Liu, X.; Fincher, L.; McKearin, D.; Liu, Q. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. Genes Dev., 2005, 19, 1674-1679.
111. Lee, Y. S.; Nakahara, K.; Pham, J. W.; Kim, K.; He, Z.; Sontheimer, E. J.; Carthew, R. W. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell, 2004, 117, 69-81.
112. Provost, P.; Dishart, D.; Doucet, J.; Frendewey, D.; Samuelsson, B.; Radmark, O. Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J., 2002, 21, 5864-5874.
113. Zhang, H.; Kolb, F. A.; Jaskiewicz, L.; Westhof, E.; Filipowicz, W. Single processing center models for human Dicer and bacterial RNase III. Cell, 2004, 118, 57-68.
114. Song, J. J.; Liu, J.; Tolia, N. H.; Schneiderman, J.; Smith, S. K.; Martienssen, R. A.; Hannon, G. J.; Joshua-Tor, L. The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes. Nat. Struct. Biol., 2003, 10, 1026-1032.
115. Yan, K. S.; Yan, S.; Farooq, A.; Han, A.; Zeng, L.; Zhou, M. M. Structure and conserved RNA binding of the PAZ domain. Nature, 2003, 426, 468-474.
116. Zhang, B.; Pan, X.; Cobb, G. P.; Anderson, T. A. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol., 2007, 302, 1-12.
117. Billy, E.; Brondani, V.; Zhang, H.; Muller, U.; Filipowicz, W. Specific interference with gene expression induced by long, double- stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc. Natl. Acad. Sci. USA, 2001, 98, 14428-14433.
118. Chendrimada, T. P.; Gregory, R. I.; Kumaraswamy, E.; Norman, J.; Cooch, N.; Nishikura, K.; Shiekhattar, R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature, 2005, 436, 740-744.
119. Lee, Y.; Hur, I.; Park, S. Y.; Kim, Y. K.; Suh, M. R.; Kim, V. N. The role of PACT in the RNA silencing pathway. EMBO J., 2006, 25, 522-532.
120. Diederichs, S.; Haber, D. A. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell, 2007, 131, 1097-1108.
121. Cifuentes, D.; Xue, H.; Taylor, D. W.; Patnode, H.; Mishima, Y.; Cheloufi, S.; Ma, E.; Mane, S.; Hannon, G. J.; Lawson, N. D.; Wolfe, S. A.; Giraldez, A. J. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science, 2010, 328, 1694-1698.
122. Song, J. J.; Smith, S. K.; Hannon, G. J.; Joshua-Tor, L. Crystal structure of Argonaute and its implications for RISC slicer activity. Science, 2004, 305, 1434-1437.
123. O'Carroll, D.; Mecklenbrauker, I.; Das, P. P.; Santana, A.; Koenig, U.; Enright, A. J.; Miska, E. A.; Tarakhovsky, A. A Slicerindependent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev., 2007, 21, 1999-2004.
124. Meister, G.; Landthaler, M.; Patkaniowska, A.; Dorsett, Y.; Teng, G.; Tuschl, T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell, 2004, 15, 185-197.
125. Gregory, R. I.; Chendrimada, T. P.; Cooch, N.; Shiekhattar, R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell, 2005, 123, 631-640.
126. Maniataki, E.; Mourelatos, Z. A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev., 2005, 19, 2979-2990.
127. Rossi, J. J. Mammalian Dicer finds a partner. EMBO Rep., 2005, 6, 927-929.
128. Melo, S. A.; Ropero, S.; Moutinho, C.; Aaltonen, L. A.; Yamamoto, H.; Calin, G. A.; Rossi, S.; Fernandez, A. F.; Carneiro, F.; Oliveira, C.; Ferreira, B.; Liu, C. G.; Villanueva, A.; Capella, G.; Schwartz, S., Jr.; Shiekhattar, R.; Esteller, M. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat. Genet., 2009, 41, 365-370.
129. Daher, A.; Longuet, M.; Dorin, D.; Bois, F.; Segeral, E.; Bannwarth, S.; Battisti, P. L.; Purcell, D. F.; Benarous, R.; Vaquero, C.; Meurs, E. F.; Gatignol, A. Two dimerization domains in the transactivation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J. Biol. Chem., 2001, 276, 33899-33905.
130. Gupta, V.; Huang, X.; Patel, R. C. The carboxy-terminal, M3 motifs of PACT and TRBP have opposite effects on PKR activity. Virology, 2003, 315, 283-291.
131. Peters, G. A.; Hartmann, R.; Qin, J.; Sen, G. C. Modular structure of PACT: distinct domains for binding and activating PKR. Mol. Cell. Biol., 2001, 21, 1908-1920.
132. Patel, R. C.; Sen, G. C. PACT, a protein activator of the interferoninduced protein kinase, PKR. EMBO J., 1998, 17, 4379-4390.
133. Garcia, M. A.; Meurs, E. F.; Esteban, M. The dsRNA protein kinase PKR: virus and cell control. Biochimie, 2007, 89, 799-811.
134. Kalai, M.; Suin, V.; Festjens, N.; Meeus, A.; Bernis, A.; Wang, X. M.; Saelens, X.; Vandenabeele, P. The caspase-generated fragments of PKR cooperate to activate full-length PKR and inhibit translation. Cell Death Differ., 2007, 14, 1050-1059.
135. Vattem, K. M.; Staschke, K. A.; Wek, R. C. Mechanism of activation of the double-stranded-RNA-dependent protein kinase, PKR: role of dimerization and cellular localization in the stimulation of PKR phosphorylation of eukaryotic initiation factor-2 (eIF2). Eur. J. Biochem., 2001, 268, 3674-3684.
136. Aaltonen, T.; Abulencia, A.; Adelman, J.; Affolder, T.; Akimoto, T.; Albrow, M. G.; Ambrose, D.; Amerio, S.; Amidei, D.; Anastassov, A.; Anikeev, K.; Annovi, A.; Antos, J.; Aoki, M.; Apollinari, G.; Arguin, J. F.; Arisawa, T.; Artikov, A.; Ashmanskas, W.; Attal, A.; Azfar, F.; Azzi-Bacchetta, P.; Azzurri, P.; Bacchetta, N.; Badgett, W.; Barbaro-Galtieri, A.; Barnes, V. E.; Barnett, B. A.; Baroiant, S.; Bartsch, V.; Bauer, G.; Bedeschi, F.; Behari, S.; Belforte, S.; Bellettini, G.; Bellinger, J.; Belloni, A.; Benjamin, D.; Beretvas, A.; Beringer, J.; Berry, T.; Bhatti, A.; Binkley, M.; Bisello, D.; Blair, R. E.; Blocker, C.; Blumenfeld, B.; Bocci, A.; Bodek, A.; Boisvert, V.; Bolla, G.; Bolshov, A.; Bortoletto, D.; Boudreau, J.; Boveia, A.; Brau, B.; Brigliadori, L.; Bromberg, C.; Brubaker, E.; Budagov, J.; Budd, H. S.; Budd, S.; Budroni, S.; Burkett, K.; Busetto, G.; Bussey, P.; Byrum, K. L.; Cabrera, S.; Campanelli, M.; Campbell, M.; Canelli, F.; Canepa, A.; Carillo, S.; Carlsmith, D.; Carosi, R.; Casarsa, M.; Castro, A.; Catastini, P.; Cauz, D.; Cavalli-Sforza, M.; Cerri, A.; Cerrito, L.; Chang, S. H.; Chen, Y. C.; Chertok, M.; Chiarelli, G.; Chlachidze, G.; Chlebana, F.; Cho, I.; Cho, K.; Chokheli, D.; Chou, J. P.; Choudalakis, G.; Chuang, S. H.; Chung, K.; Chung, W. H.; Chung, Y. S.; Ciljak, M.; et al. Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys. Rev. Lett., 2007, 98, 142001.
137. Lau, N. C.; Lim, L. P.; Weinstein, E. G.; Bartel, D. P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science, 2001, 294, 858-862.
138. Yekta, S.; Shih, I. H.; Bartel, D. P. MicroRNA-directed cleavage of HOXB8 mRNA. Science, 2004, 304, 594-596.
139. Matranga, C.; Tomari, Y.; Shin, C.; Bartel, D. P.; Zamore, P. D. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell, 2005, 123, 607-620.
140. Rand, T. A.; Petersen, S.; Du, F.; Wang, X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell, 2005, 123, 621-629.
141. Khvorova, A.; Reynolds, A.; Jayasena, S. D. Functional siRNAs and miRNAs exhibit strand bias. Cell, 2003, 115, 209-216.
142. Schwarz, D. S.; Hutvagner, G.; Du, T.; Xu, Z.; Aronin, N.; Zamore, P. D. Asymmetry in the assembly of the RNAi enzyme complex. Cell, 2003, 115, 199-208.
143. Lagos-Quintana, M.; Rauhut, R.; Lendeckel, W.; Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science, 2001, 294, 853-858.
144. Mourelatos, Z.; Dostie, J.; Paushkin, S.; Sharma, A.; Charroux, B.; Abel, L.; Rappsilber, J.; Mann, M.; Dreyfuss, G. MiRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev., 2002, 16, 720-728.
145. Zeng, Y.; Cullen, B. R. RNA interference in human cells is restricted to the cytoplasm. RNA, 2002, 8, 855-860.
146. Tomari, Y.; Zamore, P. D. MicroRNA biogenesis: drosha can't cut it without a partner. Curr. Biol., 2005, 15, R61-64.
147. Leuschner, P. J.; Ameres, S. L.; Kueng, S.; Martinez, J. Cleavage of the siRNA passenger strand during RISC assembly in human cells. EMBO Rep., 2006, 7, 314-320.
148. Macrae, I. J.; Ma, E.; Zhou, M.; Robinson, C. V.; Doudna, J. A. In vitro reconstitution of the human RISC-loading complex. Proc.Natl. Acad. Sci. USA, 2008, 105(2), 512-7.
149. Anantharaman, V.; Koonin, E. V.; Aravind, L. Comparative genomics and evolution of proteins involved in RNA metabolism. Nucleic Acids Res., 2002, 30, 1427-1464.
150. Robb, G. B.; Rana, T. M. RNA helicase A interacts with RISC in human cells and functions in RISC loading. Mol. Cell, 2007, 26, 523-537.
151. Abdelhaleem, M.; Maltais, L.; Wain, H. The human DDX and DHX gene families of putative RNA helicases. Genomics, 2003, 81, 618-622.
152. Lee, C. G.; Hurwitz, J. A new RNA helicase isolated from HeLa cells that catalytically translocates in the 3' to 5' direction. J. Biol. Chem., 1992, 267, 4398-4407.
153. Friedemann, J.; Grosse, F.; Zhang, S. Nuclear DNA helicase II (RNA helicase A) interacts with Werner syndrome helicase and stimulates its exonuclease activity. J. Biol. Chem., 2005, 280, 31303-31313.
154. Meister, G.; Landthaler, M.; Peters, L.; Chen, P. Y.; Urlaub, H.; Luhrmann, R.; Tuschl, T. Identification of novel argonauteassociated proteins. Curr. Biol., 2005, 15, 2149-2155.
155. Yoda, M.; Kawamata, T.; Paroo, Z.; Ye, X.; Iwasaki, S.; Liu, Q.; Tomari, Y. ATP-dependent human RISC assembly pathways. Nat. Struct. Mol. Biol., 2010, 17, 17-23.
156. Brennecke, J.; Stark, A.; Russell, R. B.; Cohen, S. M. Principles of microRNA-target recognition. PLoS Biol., 2005, 3, e85.
157. Doench, J. G.; Sharp, P. A. Specificity of microRNA target selection in translational repression. Genes Dev., 2004, 18, 504-511.
158. Krek, A.; Grun, D.; Poy, M. N.; Wolf, R.; Rosenberg, L.; Epstein, E. J.; MacMenamin, P.; da Piedade, I.; Gunsalus, K. C.; Stoffel, M.; Rajewsky, N. Combinatorial microRNA target predictions. Nat. Genet., 2005, 37, 495-500.
159. Lewis, B. P.; Shih, I. H.; Jones-Rhoades, M. W.; Bartel, D. P.; Burge, C. B. Prediction of mammalian microRNA targets. Cell, 2003, 115, 787-798.
160. Doench, J. G.; Petersen, C. P.; Sharp, P. A. SiRNAs can function as miRNAs. Genes Dev, 2003, 17, 438-442.
161. Saxena, S.; Jonsson, Z. O.; Dutta, A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem., 2003, 278, 44312-44319.
162. Stark, A.; Brennecke, J.; Russell, R. B.; Cohen, S. M. Identification of Drosophila MicroRNA targets. PLoS Biol., 2003, 1, E60.
163. Enright, A. J.; John, B.; Gaul, U.; Tuschl, T.; Sander, C.; Marks, D. S. MicroRNA targets in Drosophila. Genome Biol., 2003, 5, R1.
164. Cougot, N.; Babajko, S.; Seraphin, B. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol., 2004, 165, 31-40.
165. Brengues, M.; Teixeira, D.; Parker, R. Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science, 2005, 310, 486-489.
166. Sheth, U.; Parker, R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science, 2003, 300, 805-808.
167. Eystathioy, T.; Chan, E. K.; Mahler, M.; Luft, L. M.; Fritzler, M. L.; Fritzler, M. J. A panel of monoclonal antibodies to cytoplasmic GW bodies and the mRNA binding protein GW182. Hybrid Hybridomics, 2003, 22, 79-86.
168. Eystathioy, T.; Jakymiw, A.; Chan, E. K.; Seraphin, B.; Cougot, N.; Fritzler, M. J. The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA, 2003, 9, 1171-1173.
169. Wu, L.; Fan, J.; Belasco, J. G. MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl. Acad. Sci. USA, 2006, 103, 4034-4039.
170. van Dijk, E.; Cougot, N.; Meyer, S.; Babajko, S.; Wahle, E.; Seraphin, B. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J., 2002, 21, 6915-6924.
171. Coller, J.; Parker, R. General translational repression by activators of mRNA decapping. Cell, 2005, 122, 875-886.
172. Liu, J.; Carmell, M. A.; Rivas, F. V.; Marsden, C. G.; Thomson, J. M.; Song, J. J.; Hammond, S. M.; Joshua-Tor, L.; Hannon, G. J. Argonaute2 is the catalytic engine of mammalian RNAi. Science, 2004, 305, 1437-1441.
173. Meister, G.; Landthaler, M.; Dorsett, Y.; Tuschl, T. Sequencespecific inhibition of microRNA- and siRNA-induced RNA silencing. RNA, 2004, 10, 544-550.
174. Valencia-Sanchez, M. A.; Liu, J.; Hannon, G. J.; Parker, R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev., 2006, 20, 515-524.
175. Maroney, P. A.; Yu, Y.; Fisher, J.; Nilsen, T. W. Evidence that microRNAs are associated with translating messenger RNAs in human cells. Nat. Struct. Mol. Biol., 2006, 13, 1102-1107.
176. Maroney, P. A.; Yu, Y.; Nilsen, T. W. MicroRNAs, mRNAs, and Translation. Cold Spring Harb. Symp. Quant. Biol., 2006, 71, 531-535.
177. Nottrott, S.; Simard, M. J.; Richter, J. D. Human let-7a miRNA blocks protein production on actively translating polyribosomes. Nat. Struct. Mol. Biol., 2006, 13, 1108-1114.
178. Mallory, A. C.; Reinhart, B. J.; Jones-Rhoades, M. W.; Tang, G.; Zamore, P. D.; Barton, M. K.; Bartel, D. P. MicroRNA control of PHABULOSA in leaf development: importance of pairing to the microRNA 5' region. EMBO J., 2004, 23, 3356-3364.
179. Mallory, A. C.; Vaucheret, H. MicroRNAs: something important between the genes. Curr. Opin. Plant. Biol., 2004, 7, 120-125.
180. Kiriakidou, M.; Nelson, P. T.; Kouranov, A.; Fitziev, P.; Bouyioukos, C.; Mourelatos, Z.; Hatzigeorgiou, A. A combined computational- experimental approach predicts human microRNA targets. Genes Dev., 2004, 18, 1165-1178.
181. Parker, R.; Song, H. The enzymes and control of eukaryotic mRNA turnover. Nat. Struct. Mol. Biol., 2004, 11, 121-127.
182. Coller, J.; Parker, R. Eukaryotic mRNA decapping. Annu. Rev. Biochem., 2004, 73, 861-890.
183. Pillai, R. S. MicroRNA function: multiple mechanisms for a tiny RNA? RNA, 2005, 11, 1753-1761.
184. Pillai, R. S.; Bhattacharyya, S. N.; Artus, C. G.; Zoller, T.; Cougot, N.; Basyuk, E.; Bertrand, E.; Filipowicz, W. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science, 2005, 309, 1573-1576.
185. Pillai, R. S.; Artus, C. G.; Filipowicz, W. Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis. RNA, 2004, 10, 1518-1525.
186. Richter, D.; Isono, K. The mechanism of protein synthesisinitiation, elongation and termination in translation of genetic messeges. Curr. Top. Microbiol. Immunol., 1977, 76, 83-125.
187. Petersen, C. P.; Bordeleau, M. E.; Pelletier, J.; Sharp, P. A. Short RNAs repress translation after initiation in mammalian cells. Mol. Cell, 2006, 21, 533-542.
188. Kong, Y. W.; Cannell, I. G.; de Moor, C. H.; Hill, K.; Garside, P. G.; Hamilton, T. L.; Meijer, H. A.; Dobbyn, H. C.; Stoneley, M.; Spriggs, K. A.; Willis, A. E.; Bushell, M. The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc. Natl. Acad. Sci. USA, 2008, 105, 8866-8871.
189. Liu, J.; Valencia-Sanchez, M. A.; Hannon, G. J.; Parker, R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol., 2005, 7, 719-723.
190. Liu, J.; Rivas, F. V.; Wohlschlegel, J.; Yates, J. R., 3rd; Parker, R.; Hannon, G. J. A role for the P-body component GW182 in microRNA function. Nat. Cell Biol., 2005, 7, 1261-1266.
191. Kedersha, N.; Stoecklin, G.; Ayodele, M.; Yacono, P.; Lykke-Andersen, J.; Fritzler, M. J.; Scheuner, D.; Kaufman, R. J.; Golan, D. E.; Anderson, P. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell Biol., 2005, 169, 871-884.
192. Andrei, M. A.; Ingelfinger, D.; Heintzmann, R.; Achsel, T.; Rivera-Pomar, R.; Luhrmann, R. A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA, 2005, 11, 717-727.
193. Anderson, P.; Kedersha, N. RNA granules. J. Cell Biol., 2006, 172, 803-808.
194. Teixeira, D.; Sheth, U.; Valencia-Sanchez, M. A.; Brengues, M.; Parker, R. Processing bodies require RNA for assembly and contain nontranslating mRNAs. RNA, 2005, 11, 371-382.
195. Bagga, S.; Bracht, J.; Hunter, S.; Massirer, K.; Holtz, J.; Eachus, R.; Pasquinelli, A. E. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell, 2005, 122, 553-563.
196. Fischer, N.; Weis, K. The DEAD box protein Dhh1 stimulates the decapping enzyme Dcp1. EMBO J., 2002, 21, 2788-2797.
197. Coller, J. M.; Tucker, M.; Sheth, U.; Valencia-Sanchez, M. A.; Parker, R. The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA, 2001, 7, 1717-1727.
198. Gibbings, D. J.; Ciaudo, C.; Erhardt, M.; Voinnet, O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol., 2009, 11, 1143-1149.
199. Kedersha, N.; Anderson, P. Mammalian stress granules and processing bodies. Methods Enzymol., 2007, 431, 61-81.
200. Kedersha, N. L.; Gupta, M.; Li, W.; Miller, I.; Anderson, P. RNAbinding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J. Cell Biol., 1999, 147, 1431-1442.
201. Chan, S. P.; Slack, F. J. MicroRNA-Mediated Silencing Inside PBodies. RNA Biol., 2006, 3, 97-100.
202. Parker, R.; Sheth, U. P Bodies and the control of mRNA translation and degradation. Mol. Cell, 2007, 25, 635-646.
203. Jakymiw, A.; Lian, S.; Eystathioy, T.; Li, S.; Satoh, M.; Hamel, J. C.; Fritzler, M. J.; Chan, E. K. Disruption of GW bodies impairs mammalian RNA interference. Nat. Cell Biol., 2005, 7, 1267-1274.
204. Jakymiw, A.; Pauley, K. M.; Li, S.; Ikeda, K.; Lian, S.; Eystathioy, T.; Satoh, M.; Fritzler, M. J.; Chan, E. K. The role of GW/P-bodies in RNA processing and silencing. J. Cell Sci., 2007, 120, 1317-1323.
205. Pauley, K. M.; Eystathioy, T.; Jakymiw, A.; Hamel, J. C.; Fritzler, M. J.; Chan, E. K. Formation of GW bodies is a consequence of microRNA genesis. EMBO Rep., 2006, 7, 904-910.
206. Sen, G. L.; Blau, H. M. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat. Cell Biol., 2005, 7, 633-636.
207. Yang, Z.; Jakymiw, A.; Wood, M. R.; Eystathioy, T.; Rubin, R. L.; Fritzler, M. J.; Chan, E. K. GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation. J. Cell Sci., 2004, 117, 5567-5578.
208. Eystathioy, T.; Chan, E. K.; Tenenbaum, S. A.; Keene, J. D.; Griffith, K.; Fritzler, M. J. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol. Biol. Cell, 2002, 13, 1338-1351.
209. Behm-Ansmant, I.; Rehwinkel, J.; Doerks, T.; Stark, A.; Bork, P.; Izaurralde, E. MRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev., 2006, 20, 1885-1898.
210. Behm-Ansmant, I.; Rehwinkel, J.; Izaurralde, E. MicroRNAs Silence Gene Expression by Repressing Protein Expression and/or by Promoting mRNA Decay. Cold Spring Harb. Symp. Quant. Biol., 2006, 71, 523-530.
211. Ding, L.; Han, M. GW182 family proteins are crucial for microRNA-mediated gene silencing. Trends Cell Biol., 2007, 17, 411-416.
212. Ikeda, K.; Satoh, M.; Pauley, K. M.; Fritzler, M. J.; Reeves, W. H.; Chan, E. K. Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J. Immunol. Methods, 2006, 317, 38-44.
213. Chu, C. Y.; Rana, T. M. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol., 2006, 4, e210.
214. Ferraiuolo, M. A.; Basak, S.; Dostie, J.; Murray, E. L.; Schoenberg, D. R.; Sonenberg, N. A role for the eIF4E-binding protein 4E-T in P-body formation and mRNA decay. J. Cell Biol., 2005, 170, 913-924.
215. Caudy, A. A.; Myers, M.; Hannon, G. J.; Hammond, S. M. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev., 2002, 16, 2491-2496.
216. Tanaka, Y.; Kozu, T. MiRNA in disease and therapeutic development. Tanpakushitsu Kakusan Koso, 2006, 51, 2509-2514.
217. Yang, W.; Chendrimada, T. P.; Wang, Q.; Higuchi, M.; Seeburg, P. H.; Shiekhattar, R.; Nishikura, K. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol., 2006, 13, 13-21.
218. Kahvejian, A.; Svitkin, Y. V.; Sukarieh, R.; M'Boutchou, M. N.; Sonenberg, N. Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev., 2005, 19, 104-113.
219. Bhattacharyya, S. N.; Habermacher, R.; Martine, U.; Closs, E. I.; Filipowicz, W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell, 2006, 125, 1111-1124.
220. Bhattacharyya, S. N.; Habermacher, R.; Martine, U.; Closs, E. I.; Filipowicz, W. Stress-induced Reversal of MicroRNA Repression and mRNA P-body Localization in Human Cells. Cold Spring Harb. Symp. Quant. Biol., 2006, 71, 513-521.
221. Jakymiw, A.; Ikeda, K.; Fritzler, M. J.; Reeves, W. H.; Satoh, M.; Chan, E. K. Autoimmune targeting of key components of RNA interference. Arthritis Res. Ther., 2006, 8, R87.
222. Liao, J. Y.; Ma, L. M.; Guo, Y. H.; Zhang, Y. C.; Zhou, H.; Shao, P.; Chen, Y. Q.; Qu, L. H. Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3' trailers. PLoS One, 2010, 5, e10563.
223. Marcon, E.; Babak, T.; Chua, G.; Hughes, T.; Moens, P. B. MiRNA and piRNA localization in the male mammalian meiotic nucleus. Chromosome Res., 2008, 16, 243-260
224. Politz, J. C.; Zhang, F.; Pederson, T. MicroRNA-206 colocalizes with ribosome-rich regions in both the nucleolus and cytoplasm of rat myogenic cells. Proc. Natl. Acad. Sci. USA, 2006, 103, 18957-18962.
225. Robb, G. B.; Brown, K. M.; Khurana, J.; Rana, T. M. Specific and potent RNAi in the nucleus of human cells. Nat. Struct. Mol. Biol., 2005, 12, 133-137.
226. Guang, S.; Bochner, A. F.; Pavelec, D. M.; Burkhart, K. B.; Harding, S.; Lachowiec, J.; Kennedy, S. An Argonaute transports siRNAs from the cytoplasm to the nucleus. Science, 2008, 321, 537-541.
227. Meister, G. Molecular biology. RNA interference in the nucleus. Science, 2008, 321, 496-497.
228. Blow, M. J.; Grocock, R. J.; van Dongen, S.; Enright, A. J.; Dicks, E.; Futreal, P. A.; Wooster, R.; Stratton, M. R. RNA editing of human microRNAs. Genome Biol., 2006, 7, R27.
229. Desterro, J. M.; Keegan, L. P.; Lafarga, M.; Berciano, M. T.; O'Connell, M.; Carmo-Fonseca, M. Dynamic association of RNAediting enzymes with the nucleolus. J. Cell Sci., 2003, 116, 1805-1818.
230. Luciano, D. J.; Mirsky, H.; Vendetti, N. J.; Maas, S. RNA editing of a miRNA precursor. RNA, 2004, 10, 1174-1177.
231. Kawahara, Y.; Zinshteyn, B.; Sethupathy, P.; Iizasa, H.; Hatzigeorgiou, A. G.; Nishikura, K. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science, 2007, 315, 1137-1140.
232. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell, 2000, 100, 57-70.
233. Croce, C. M. Oncogenes and cancer. N. Engl. J. Med., 2008, 358, 502-511.
234. Konopka, J. B.; Watanabe, S. M.; Singer, J. W.; Collins, S. J.; Witte, O. N. Cell lines and clinical isolates derived from Ph1- positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc. Natl. Acad. Sci. USA, 1985, 82, 1810-1814.
235. Tsujimoto, Y.; Jaffe, E.; Cossman, J.; Gorham, J.; Nowell, P. C.; Croce, C. M. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature, 1985, 315, 340-343.
236. Sherr, C. J. Principles of tumor suppression. Cell, 2004, 116, 235-246.
237. Wu, W.; Sun, M.; Zou, G. M.; Chen, J. MicroRNA and cancer: Current status and prospective. Int. J. Cancer, 2007, 120, 953-960.
238. Dalmay, T.; Edwards, D. R. MicroRNAs and the hallmarks of cancer. Oncogene, 2006, 25, 6170-6175.
239. Esquela-Kerscher, A.; Slack, F. J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 2006, 6, 259-269.
240. Hwang, H. W.; Mendell, J. T. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer, 2006, 94, 776-780.
241. Volinia, S.; Calin, G. A.; Liu, C. G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; Prueitt, R. L.; Yanaihara, N.; Lanza, G.; Scarpa, A.; Vecchione, A.; Negrini, M.; Harris, C. C.; Croce, C. M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA, 2006, 103, 2257-2261.
242. Calin, G. A.; Liu, C. G.; Sevignani, C.; Ferracin, M.; Felli, N.; Dumitru, C. D.; Shimizu, M.; Cimmino, A.; Zupo, S.; Dono, M.; Dell'Aquila, M. L.; Alder, H.; Rassenti, L.; Kipps, T. J.; Bullrich, F.; Negrini, M.; Croce, C. M. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. USA, 2004, 101, 11755-11760.
243. Lagos-Quintana, M.; Rauhut, R.; Yalcin, A.; Meyer, J.; Lendeckel, W.; Tuschl, T. Identification of tissue-specific microRNAs from mouse. Curr. Biol., 2002, 12, 735-739.
244. Reinhart, B.J.; Slack, F.J.; Basson, M.; Pasquinelli, A.E.; Bettinger, J.C.; Rougvie, A.E.; Horvitz, H.R.; Ruvkun, G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 2000, 403, 901-906.
245. Calin, G. A.; Sevignani, C.; Dumitru, C. D.; Hyslop, T.; Noch, E.; Yendamuri, S.; Shimizu, M.; Rattan, S.; Bullrich, F.; Negrini, M.; Croce, C. M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA, 2004, 101, 2999-3004.
246. Nobes, C. D.; Hall, A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol., 1999, 144, 1235-1244.
247. Holzer, M.; Rodel, L.; Seeger, G.; Gartner, U.; Narz, F.; Janke, C.; Heumann, R.; Arendt, T. Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology. Neuroscience, 2001, 105, 1041-1054.
248. Vasioukhin, V.; Bauer, C.; Degenstein, L.; Wise, B.; Fuchs, E. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell, 2001, 104, 605-617.
249. Walsh, A. B.; Bar-Sagi, D. Differential activation of the Rac pathway by Ha-Ras and K-Ras. J. Biol. Chem., 2001, 276, 15609-15615.
250. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res. 1989, 49, 4682-4689.
251. Johnson, S. M.; Grosshans, H.; Shingara, J.; Byrom, M.; Jarvis, R.; Cheng, A.; Labourier, E.; Reinert, K. L.; Brown, D.; Slack, F. J. RAS is regulated by the let-7 microRNA family. Cell, 2005, 120, 635-647.
252. Lee, C. T.; Risom, T.; Strauss, W. M. Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny. DNA Cell Biol., 2007, 26, 209-218.
253. Johnson, C. D.; Esquela-Kerscher, A.; Stefani, G.; Byrom, M.; Kelnar, K.; Ovcharenko, D.; Wilson, M.; Wang, X.; Shelton, J.; Shingara, J.; Chin, L.; Brown, D.; Slack, F. J. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res., 2007, 67, 7713-7722.
254. Akao, Y.; Nakagawa, Y.; Naoe, T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull., 2006, 29, 903-906.
255. Reeves, R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene, 2001, 277, 63-81.
256. Flake, G. P.; Andersen, J.; Dixon, D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ. Health Perspect., 2003, 111, 1037-1054.
257. Sarhadi, V. K.; Wikman, H.; Salmenkivi, K.; Kuosma, E.; Sioris, T.; Salo, J.; Karjalainen, A.; Knuutila, S.; Anttila, S. Increased expression of high mobility group A proteins in lung cancer. J. Pathol., 2006, 209, 206-212.
258. Ligon, A. H.; Morton, C. C. Leiomyomata: heritability and cytogenetic studies. Hum. Reprod. Update, 2001, 7, 8-14.
259. Koscianska, E.; Baev, V.; Skreka, K.; Oikonomaki, K.; Rusinov, V.; Tabler, M.; Kalantidis, K. Prediction and preliminary validation of oncogene regulation by miRNAs. BMC Mol. Biol., 2007, 8, 79.
260. Kumar, M. S.; Lu, J.; Mercer, K. L.; Golub, T. R.; Jacks, T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet., 2007, 39, 673-677.
261. Cimmino, A.; Calin, G. A.; Fabbri, M.; Iorio, M. V.; Ferracin, M.; Shimizu, M.; Wojcik, S. E.; Aqeilan, R. I.; Zupo, S.; Dono, M.; Rassenti, L.; Alder, H.; Volinia, S.; Liu, C. G.; Kipps, T. J.; Negrini, M.; Croce, C. M. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA, 2005, 102, 13944-13949.
262. Calin, G. A.; Dumitru, C. D.; Shimizu, M.; Bichi, R.; Zupo, S.; Noch, E.; Aldler, H.; Rattan, S.; Keating, M.; Rai, K.; Rassenti, L.; Kipps, T.; Negrini, M.; Bullrich, F.; Croce, C. M. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 2002, 99, 15524-15529.
263. Xia, L.; Zhang, D.; Du, R.; Pan, Y.; Zhao, L.; Sun, S.; Hong, L.; Liu, J.; Fan, D. MiR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer, 2008, 123, 372-379.
264. Cory, S.; Adams, J. M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer, 2002, 2, 647-656.
265. Sanchez-Beato, M.; Sanchez-Aguilera, A.; Piris, M. A. Cell cycle deregulation in B-cell lymphomas. Blood, 2003, 101, 1220-1235.
266. Kitada, S.; Krajewska, M.; Zhang, X.; Scudiero, D.; Zapata, J. M.; Wang, H. G.; Shabaik, A.; Tudor, G.; Krajewski, S.; Myers, T. G.; Johnson, G. S.; Sausville, E. A.; Reed, J. C. Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am. J. Pathol., 1998, 152, 51-61.
267. Calin, G. A.; Cimmino, A.; Fabbri, M.; Ferracin, M.; Wojcik, S. E.; Shimizu, M.; Taccioli, C.; Zanesi, N.; Garzon, R.; Aqeilan, R. I.; Alder, H.; Volinia, S.; Rassenti, L.; Liu, X.; Liu, C. G.; Kipps, T. J.; Negrini, M.; Croce, C. M. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl. Acad. Sci. USA, 2008, 105, 5166-5171.
268. Jiang, X.; Wang, X. Cytochrome C-mediated apoptosis. Annu. Rev. Biochem., 2004, 73, 87-106.
269. Cory, S.; Huang, D. C.; Adams, J. M. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene, 2003, 22, 8590-8607.
270. Kaufmann, S. H.; Earnshaw, W. C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res., 2000, 256, 42-49.
271. Kaufmann, S. H.; Gores, G. J. Apoptosis in cancer: cause and cure. Bioessays, 2000, 22, 1007-1017.
272. Cao, X.; Rodarte, C.; Zhang, L.; Morgan, C. D.; Littlejohn, J.; Smythe, W. R. Bcl2/bcl-xL inhibitor engenders apoptosis and increases chemosensitivity in mesothelioma. Cancer Biol. Ther., 2007, 6, 246-252.
273. Linsley, P. S.; Schelter, J.; Burchard, J.; Kibukawa, M.; Martin, M. M.; Bartz, S. R.; Johnson, J. M.; Cummins, J. M.; Raymond, C. K.; Dai, H.; Chau, N.; Cleary, M.; Jackson, A. L.; Carleton, M.; Lim, L. Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression. Mol. Cell Biol., 2007, 27, 2240-2252.
274. Chan, J. A.; Krichevsky, A. M.; Kosik, K. S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res., 2005, 65, 6029-6033.
275. Meng, F.; Henson, R.; Wehbe-Janek, H.; Ghoshal, K.; Jacob, S. T.; Patel, T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 2007, 133, 647-658.
276. Dillhoff, M.; Liu, J.; Frankel, W.; Croce, C.; Bloomston, M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J. Gastrointest. Surg., 2008, 12(12), 2171-6.
277. Asangani, I. A.; Rasheed, S. A.; Nikolova, D. A.; Leupold, J. H.; Colburn, N. H.; Post, S.; Allgayer, H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 2008, 27, 2128-2136.
278. Iorio, M. V.; Ferracin, M.; Liu, C. G.; Veronese, A.; Spizzo, R.; Sabbioni, S.; Magri, E.; Pedriali, M.; Fabbri, M.; Campiglio, M.; Menard, S.; Palazzo, J. P.; Rosenberg, A.; Musiani, P.; Volinia, S.; Nenci, I.; Calin, G. A.; Querzoli, P.; Negrini, M.; Croce, C. M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 2005, 65, 7065-7070.
279. Roldo, C.; Missiaglia, E.; Hagan, J. P.; Falconi, M.; Capelli, P.; Bersani, S.; Calin, G. A.; Volinia, S.; Liu, C. G.; Scarpa, A.; Croce, C. M. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol., 2006, 24, 4677-4684.
280. Zhu, S.; Wu, H.; Wu, F.; Nie, D.; Sheng, S.; Mo, Y. Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res., 2008, 18, 350-359.
281. Lu, Z.; Liu, M.; Stribinskis, V.; Klinge, C. M.; Ramos, K. S.; Colburn, N. H.; Li, Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene, 2008, 27, 4373-4379.
282. Zhu, S.; Si, M. L.; Wu, H.; Mo, Y. Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem., 2007, 282(19), 14328-36.
283. Kim, R. H.; Mak, T. W. Tumours and tremors: how PTEN regulation underlies both. Br. J. Cancer, 2006, 94, 620-624.
284. Iijima, M.; Devreotes, P. Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell, 2002, 109, 599-610.
285. Sansal, I.; Sellers, W. R. The biology and clinical relevance of the PTEN tumor suppressor pathway. J. Clin. Oncol., 2004, 22, 2954-2963.
286. Park, M. J.; Kim, M. S.; Park, I. C.; Kang, H. S.; Yoo, H.; Park, S. H.; Rhee, C. H.; Hong, S. I.; Lee, S. H. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res., 2002, 62, 6318-6322.
287. Perry, S. V. Vertebrate tropomyosin: distribution, properties and function. J. Muscle Res. Cell Motil., 2001, 22, 5-49.
288. Boyd, J.; Risinger, J. I.; Wiseman, R. W.; Merrick, B. A.; Selkirk, J. K.; Barrett, J. C. Regulation of microfilament organization and anchorage-independent growth by tropomyosin 1. Proc. Natl. Acad. Sci. USA, 1995, 92, 11534-11538.
289. Frankel, L. B.; Christoffersen, N. R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A. H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 2008, 283, 1026-1033.
290. Yin, S.; Lockett, J.; Meng, Y.; Biliran, H., Jr.; Blouse, G. E.; Li, X.; Reddy, N.; Zhao, Z.; Lin, X.; Anagli, J.; Cher, M. L.; Sheng, S. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res., 2006, 66, 4173-4181.
291. Leupold, J. H.; Yang, H. S.; Colburn, N. H.; Asangani, I.; Post, S.; Allgayer, H. Tumor suppressor Pdcd4 inhibits invasion/ intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene, 2007, 26, 4550-4562.
292. Stephens, R. W.; Nielsen, H. J.; Christensen, I. J.; Thorlacius-Ussing, O.; Sorensen, S.; Dano, K.; Brunner, N. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J. Natl. Cancer Inst., 1999, 91, 869-874.
293. Mendell, J. T. MiRiad roles for the miR-17-92 cluster in development and disease. Cell, 2008, 133, 217-222.
294. Ota, A.; Tagawa, H.; Karnan, S.; Tsuzuki, S.; Karpas, A.; Kira, S.; Yoshida, Y.; Seto, M. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res., 2004, 64, 3087-3095.
295. Giangrande, P. H.; Zhu, W.; Rempel, R. E.; Laakso, N.; Nevins, J. R. Combinatorial gene control involving E2F and E Box family members. EMBO J., 2004, 23, 1336-1347.
296. Hammond, S. M. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev., 2006, 16, 4-9.
297. Petrocca, F.; Visone, R.; Onelli, M. R.; Shah, M. H.; Nicoloso, M. S.; de Martino, I.; Iliopoulos, D.; Pilozzi, E.; Liu, C. G.; Negrini, M.; Cavazzini, L.; Volinia, S.; Alder, H.; Ruco, L. P.; Baldassarre, G.; Croce, C. M.; Vecchione, A. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell, 2008, 13, 272-286.
298. Hayashita, Y.; Osada, H.; Tatematsu, Y.; Yamada, H.; Yanagisawa, K.; Tomida, S.; Yatabe, Y.; Kawahara, K.; Sekido, Y.; Takahashi, T. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res., 2005, 65, 9628-9632.
299. He, L.; Thomson, J. M.; Hemann, M. T.; Hernando-Monge, E.; Mu, D.; Goodson, S.; Powers, S.; Cordon-Cardo, C.; Lowe, S. W.; Hannon, G. J.; Hammond, S. M. A microRNA polycistron as a potential human oncogene. Nature, 2005, 435, 828-833.
300. Dang, C. V.; Resar, L. M.; Emison, E.; Kim, S.; Li, Q.; Prescott, J. E.; Wonsey, D.; Zeller, K. Function of the c-Myc oncogenic transcription factor. Exp. Cell Res., 1999, 253, 63-77.
301. Cole, M. D.; McMahon, S. B. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene, 1999, 18, 2916-2924.
302. Eisenman, R. N. Deconstructing myc. Genes Dev., 2001, 15, 2023-2030.
303. Fernandez, P. C.; Frank, S. R.; Wang, L.; Schroeder, M.; Liu, S.; Greene, J.; Cocito, A.; Amati, B. Genomic targets of the human c- Myc protein. Genes Dev., 2003, 17, 1115-1129.
304. Wu, L.; Timmers, C.; Maiti, B.; Saavedra, H. I.; Sang, L.; Chong, G. T.; Nuckolls, F.; Giangrande, P.; Wright, F. A.; Field, S. J.; Greenberg, M. E.; Orkin, S.; Nevins, J. R.; Robinson, M. L.; Leone, G. The E2F1-3 transcription factors are essential for cellular proliferation. Nature, 2001, 414, 457-462.
305. DeGregori, J.; Leone, G.; Miron, A.; Jakoi, L.; Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA, 1997, 94, 7245-7250.
306. Johnson, D. G.; Schwarz, J. K.; Cress, W. D.; Nevins, J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature, 1993, 365, 349-352.
307. Nahle, Z.; Polakoff, J.; Davuluri, R. V.; McCurrach, M. E.; Jacobson, M. D.; Narita, M.; Zhang, M. Q.; Lazebnik, Y.; Bar-Sagi, D.; Lowe, S. W. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol., 2002, 4, 859-864.
308. Furukawa, Y.; Nishimura, N.; Furukawa, Y.; Satoh, M.; Endo, H.; Iwase, S.; Yamada, H.; Matsuda, M.; Kano, Y.; Nakamura, M. Apaf-1 is a mediator of E2F-1-induced apoptosis. J. Biol. Chem., 2002, 277, 39760-39768.
309. Urist, M.; Tanaka, T.; Poyurovsky, M. V.; Prives, C. P73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev., 2004, 18, 3041-3054.
310. Lin, W. C.; Lin, F. T.; Nevins, J. R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev., 2001, 15, 1833-1844.
311. Kowalik, T. F.; DeGregori, J.; Schwarz, J. K.; Nevins, J. R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol., 1995, 69, 2491-2500.
312. Ginsberg, D. E2F1 pathways to apoptosis. FEBS Lett., 2002, 529, 122-125.
313. Coller, H. A.; Forman, J. J.; Legesse-Miller, A. Myc'ed messages: myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. PLoS Genet., 2007, 3, e146.
314. Johnson, D. G.; Cress, W. D.; Jakoi, L.; Nevins, J. R. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA, 1994, 91, 12823-12827.
315. Thalmeier, K.; Synovzik, H.; Mertz, R.; Winnacker, E. L.; Lipp, M. Nuclear factor E2F mediates basic transcription and transactivation by E1a of the human MYC promoter. Genes Dev., 1989, 3, 527-536.
316. Mangan, S.; Alon, U. Structure and function of the feed-forward loop network motif. Proc. Natl. Acad. Sci. USA, 2003, 100, 11980-11985.
317. Zhang, X. L.; Fu, W. L.; Zhao, H. X.; Zhou, L. X.; Huang, J. F.; Wang, J. H. Molecular studies of loss of heterozygosity in Chinese sporadic retinoblastoma patients. Clin. Chim. Acta, 2005, 358, 75-80.
318. Lin, Y. W.; Sheu, J. C.; Liu, L. Y.; Chen, C. H.; Lee, H. S.; Huang, G. T.; Wang, J. T.; Lee, P. H.; Lu, F. J. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur. J. Cancer, 1999, 35, 1730-1734.
319. Eiriksdottir, G.; Johannesdottir, G.; Ingvarsson, S.; Bjornsdottir, I. B.; Jonasson, J. G.; Agnarsson, B. A.; Hallgrimsson, J.; Gudmundsson, J.; Egilsson, V.; Sigurdsson, H.; Barkardottir, R. B. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur. J. Cancer, 1998, 34, 2076-2081.
320. Shao, J.; Li, Y.; Wu, Q.; Liang, X.; Yu, X.; Huang, L.; Hou, J.; Huang, X.; Ernberg, I.; Hu, L. F.; Zeng, Y. High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China. Chin. Med. J. (Engl), 2002, 115, 571-575.
321. Hossain, A.; Kuo, M. T.; Saunders, G. F. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell. Biol., 2006, 26, 8191-8201.
322. Yan, J.; Tsai, S. Y.; Tsai, M. J. SRC-3/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol. Sin., 2006, 27, 387-394.
323. Anzick, S. L.; Kononen, J.; Walker, R. L.; Azorsa, D. O.; Tanner, M. M.; Guan, X. Y.; Sauter, G.; Kallioniemi, O. P.; Trent, J. M.; Meltzer, P. S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science, 1997, 277, 965-968.
324. Louie, M. C.; Zou, J. X.; Rabinovich, A.; Chen, H. W. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol. Cell. Biol., 2004, 24, 5157-5171.
325. Oh, A.; List, H. J.; Reiter, R.; Mani, A.; Zhang, Y.; Gehan, E.; Wellstein, A.; Riegel, A. T. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res., 2004, 64, 8299-8308.
326. Wang, Z.; Rose, D. W.; Hermanson, O.; Liu, F.; Herman, T.; Wu, W.; Szeto, D.; Gleiberman, A.; Krones, A.; Pratt, K.; Rosenfeld, R.; Glass, C. K.; Rosenfeld, M. G. Regulation of somatic growth by the p160 coactivator p/CIP. Proc. Natl. Acad. Sci. USA, 2000, 97, 13549-13554.
327. Zhou, G.; Hashimoto, Y.; Kwak, I.; Tsai, S. Y.; Tsai, M. J. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol. Cell Biol., 2003, 23, 7742-7755.
328. Han, S. J.; DeMayo, F. J.; Xu, J.; Tsai, S. Y.; Tsai, M. J.; O'Malley, B. W. Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol. Endocrinol., 2006, 20, 45-55.
329. Werbajh, S.; Nojek, I.; Lanz, R.; Costas, M. A. RAC-3 is a NFkappa B coactivator. FEBS Lett., 2000, 485, 195-199.
330. Griffiths-Jones, S.; Grocock, R. J.; van Dongen, S.; Bateman, A.; Enright, A. J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res., 2006, 34, D140-144.
331. Babak, T.; Zhang, W.; Morris, Q.; Blencowe, B. J.; Hughes, T. R. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA, 2004, 10, 1813-1819.
332. Nelson, P. T.; Baldwin, D. A.; Scearce, L. M.; Oberholtzer, J. C.; Tobias, J. W.; Mourelatos, Z. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat. Methods, 2004, 1, 155-161.
333. Barad, O.; Meiri, E.; Avniel, A.; Aharonov, R.; Barzilai, A.; Bentwich, I.; Einav, U.; Gilad, S.; Hurban, P.; Karov, Y.; Lobenhofer, E. K.; Sharon, E.; Shiboleth, Y. M.; Shtutman, M.; Bentwich, Z.; Einat, P. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res., 2004, 14, 2486-2494.
334. Sun, Y.; Koo, S.; White, N.; Peralta, E.; Esau, C.; Dean, N. M.; Perera, R. J. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res., 2004, 32, e188.
335. Chen, J.; Lozach, J.; Garcia, E. W.; Barnes, B.; Luo, S.; Mikoulitch, I.; Zhou, L.; Schroth, G.; Fan, J. B. Highly sensitive and specific microRNA expression profiling using BeadArray technology. Nucleic Acids Res., 2008, 36, e87.
336. Chen, Y. T.; Kitabayashi, N.; Zhou, X. K.; Fahey, T. J., 3rd.; Scognamiglio, T. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod. Pathol., 2008, 21, 1139-1146.
337. Mattie, M. D.; Benz, C. C.; Bowers, J.; Sensinger, K.; Wong, L.; Scott, G. K.; Fedele, V.; Ginzinger, D.; Getts, R.; Haqq, C. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer, 2006, 5, 24.
338. Jiang, J.; Gusev, Y.; Aderca, I.; Mettler, T. A.; Nagorney, D. M.; Brackett, D. J.; Roberts, L. R.; Schmittgen, T. D. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res., 2008, 14, 419-427.
339. Markou, A.; Tsaroucha, E. G.; Kaklamanis, L.; Fotinou, M.; Georgoulias, V.; Lianidou, E. S. Prognostic value of mature microRNA- 21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin. Chem., 2008, 54, 1696-1704.
340. Yanaihara, N.; Caplen, N.; Bowman, E.; Seike, M.; Kumamoto, K.; Yi, M.; Stephens, R. M.; Okamoto, A.; Yokota, J.; Tanaka, T.; Calin, G. A.; Liu, C. G.; Croce, C. M.; Harris, C. C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9, 189-198.
341. Meng, F.; Henson, R.; Lang, M.; Wehbe, H.; Maheshwari, S.; Mendell, J. T.; Jiang, J.; Schmittgen, T. D.; Patel, T. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology, 2006, 130, 2113-2129.
342. Miller, T. E.; Ghoshal, K.; Ramaswamy, B.; Roy, S.; Datta, J.; Shapiro, C. L.; Jacob, S.; Majumder, S. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J. Biol. Chem., 2008, 283, 29897-29903.
343. Svoboda, M.; Izakovicova Holla, L.; Sefr, R.; Vrtkova, I.; Kocakova, I.; Tichy, B.; Dvorak, J. Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer. Int. J. Oncol., 2008, 33, 541-547.
344. Calin, G. A.; Ferracin, M.; Cimmino, A.; Di Leva, G.; Shimizu, M.; Wojcik, S. E.; Iorio, M. V.; Visone, R.; Sever, N. I.; Fabbri, M.; Iuliano, R.; Palumbo, T.; Pichiorri, F.; Roldo, C.; Garzon, R.; Sevignani, C.; Rassenti, L.; Alder, H.; Volinia, S.; Liu, C. G.; Kipps, T. J.; Negrini, M.; Croce, C. M. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med., 2005, 353, 1793-1801.
345. Chin, L. J.; Ratner, E.; Leng, S.; Zhai, R.; Nallur, S.; Babar, I.; Muller, R. U.; Straka, E.; Su, L.; Burki, E. A.; Crowell, R. E.; Patel, R.; Kulkarni, T.; Homer, R.; Zelterman, D.; Kidd, K. K.; Zhu, Y.; Christiani, D. C.; Belinsky, S. A.; Slack, F. J.; Weidhaas, J. B. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res., 2008, 68, 8535-8540.
346. Ma, L.; Teruya-Feldstein, J.; Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 2007, 449, 682-688.
347. Hu, Z.; Chen, X.; Zhao, Y.; Tian, T.; Jin, G.; Shu, Y.; Chen, Y.; Xu, L.; Zen, K.; Zhang, C.; Shen, H. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol., 2010, 28, 1721-1726.
348. Lodes, M. J.; Caraballo, M.; Suciu, D.; Munro, S.; Kumar, A.; Anderson, B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One, 2009, 4, e6229.
349. Hausler, S. F.; Keller, A.; Chandran, P. A.; Ziegler, K.; Zipp, K.; Heuer, S.; Krockenberger, M.; Engel, J. B.; Honig, A.; Scheffler, M.; Dietl, J.; Wischhusen, J. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br. J. Cancer, 2010, 103, 693-700.
350. Keller, A.; Leidinger, P.; Borries, A.; Wendschlag, A.; Wucherpfennig, F.; Scheffler, M.; Huwer, H.; Lenhof, H. P.; Meese, E. miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer, 2009, 9, 353.
351. Leidinger, P.; Keller, A.; Borries, A.; Reichrath, J.; Rass, K.; Jager, S. U.; Lenhof, H. P.; Meese, E. High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer, 2010, 10, 262.
352. Hanke, M.; Hoefig, K.; Merz, H.; Feller, A. C.; Kausch, I.; Jocham, D.; Warnecke, J. M.; Sczakiel, G. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA- 182 are related to urinary bladder cancer. Urol. Oncol., 2009, [Epub ahead of print].
353. Michael, A.; Bajracharya, S. D.; Yuen, P. S.; Zhou, H.; Star, R. A.; Illei, G. G.; Alevizos, I. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis., 2010, 16, 34-38.
354. Wang, K.; Zhang, S.; Weber, J.; Baxter, D.; Galas, D. J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res., 2010, [Epub ahead of print].
355. Chen, X.; Ba, Y.; Ma, L.; Cai, X.; Yin, Y.; Wang, K.; Guo, J.; Zhang, Y.; Chen, J.; Guo, X.; Li, Q.; Li, X.; Wang, W.; Zhang, Y.; Wang, J.; Jiang, X.; Xiang, Y.; Xu, C.; Zheng, P.; Zhang, J.; Li, R.; Zhang, H.; Shang, X.; Gong, T.; Ning, G.; Wang, J.; Zen, K.; Zhang, J.; Zhang, C. Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res., 2008, 18, 997-1006.
356. Mitchell, P. S.; Parkin, R. K.; Kroh, E. M.; Fritz, B. R.; Wyman, S. K.; Pogosova-Agadjanyan, E. L.; Peterson, A.; Noteboom, J.; O'Briant, K. C.; Allen, A.; Lin, D. W.; Urban, N.; Drescher, C. W.; Knudsen, B. S.; Stirewalt, D. L.; Gentleman, R.; Vessella, R. L.; Nelson, P. S.; Martin, D. B.; Tewari, M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA, 2008, 105, 10513-10518.
357. El-Hefnawy, T.; Raja, S.; Kelly, L.; Bigbee, W. L.; Kirkwood, J. M.; Luketich, J. D.; Godfrey, T. E. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem., 2004, 50, 564-573.
358. Sisco, K. L. Is RNA in serum bound to nucleoprotein complexes? Clin. Chem., 2001, 47, 1744-1745.
359. Wong, T. S.; Liu, X. B.; Wong, B. Y.; Ng, R. W.; Yuen, A. P.; Wei, W. I. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin. Cancer Res., 2008, 14, 2588-2592.
360. Gaarz, A.; Debey-Pascher, S.; Classen, S.; Eggle, D.; Gathof, B.; Chen, J.; Fan, J. B.; Voss, T.; Schultze, J. L.; Staratschek-Jox, A. Ead array-based microrna expression profiling of peripheral blood and the impact of different RNA isolation approaches. J. Mol. Diagn., 2010, 12, 335-344.
361. Schetter, A. J.; Leung, S. Y.; Sohn, J. J.; Zanetti, K. A.; Bowman, E. D.; Yanaihara, N.; Yuen, S. T.; Chan, T. L.; Kwong, D. L.; Au, G. K.; Liu, C. G.; Calin, G. A.; Croce, C. M.; Harris, C. C. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 2008, 299, 425-436.
362. Elmen, J.; Lindow, M.; Schutz, S.; Lawrence, M.; Petri, A.; Obad, S.; Lindholm, M.; Hedtjarn, M.; Hansen, H. F.; Berger, U.; Gullans, S.; Kearney, P.; Sarnow, P.; Straarup, E. M.; Kauppinen, S. LNA-mediated microRNA silencing in non-human primates. Nature, 2008, 452, 896-899.
363. Zhang, B.; Pan, X.; Anderson, T. A. MicroRNA: a new player in stem cells. J Cell Physiol, 2006, 209, 266-269.
364. Zhang, B.; Pan, X.; Wang, Q.; Cobb, G. P.; Anderson, T. A. Computational identification of microRNAs and their targets. Comput. Biol. Chem., 2006, 30, 395-407.
365. Yang, M.; Mattes, J. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol. Ther., 2008, 117, 94-104.
366. Lewis, D. L.; Hagstrom, J. E.; Loomis, A. G.; Wolff, J. A.; Herweijer, H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet., 2002, 32, 107-108.
367. Lefesvre, P.; Attema, J.; van Bekkum, D. A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer. BMC Mol. Biol., 2002, 3, 12.
368. Boden, D.; Pusch, O.; Lee, F.; Tucker, L.; Ramratnam, B. Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors. Mol. Ther., 2004, 9, 396-402.
369. Rubinson, D. A.; Dillon, C. P.; Kwiatkowski, A. V.; Sievers, C.; Yang, L.; Kopinja, J.; Rooney, D. L.; Zhang, M.; Ihrig, M. M.; McManus, M. T.; Gertler, F. B.; Scott, M. L.; Van Parijs, L. A lentivirus- based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet., 2003, 33, 401-406.
370. Szulc, J.; Wiznerowicz, M.; Sauvain, M. O.; Trono, D.; Aebischer, P. A versatile tool for conditional gene expression and knockdown. Nat. Methods, 2006, 3, 109-116.
371. Thomas, C. E.; Ehrhardt, A.; Kay, M. A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet., 2003, 4, 346-358.
372. Harvey, B. G.; Hackett, N. R.; El-Sawy, T.; Rosengart, T. K.; Hirschowitz, E. A.; Lieberman, M. D.; Lesser, M. L.; Crystal, R. G. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J. Virol., 1999, 73, 6729-6742.
373. Yang, Y.; Li, Q.; Ertl, H. C.; Wilson, J. M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol., 1995, 69, 2004-2015.
374. Sinn, P. L.; Sauter, S. L.; McCray, P. B., Jr. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. Gene Ther., 2005, 12, 1089-1098.
375. Hackett, C. S.; Geurts, A. M.; Hackett, P. B. Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapy. Genome Biol., 2007, 8(Suppl 1), S12.
376. Miller, A. D. The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy. Curr. Med. Chem., 2003, 10, 1195-1211.
377. Soutschek, J.; Akinc, A.; Bramlage, B.; Charisse, K.; Constien, R.; Donoghue, M.; Elbashir, S.; Geick, A.; Hadwiger, P.; Harborth, J.; John, M.; Kesavan, V.; Lavine, G.; Pandey, R. K.; Racie, T.; Rajeev, K. G.; Rohl, I.; Toudjarska, I.; Wang, G.; Wuschko, S.; Bumcrot, D.; Koteliansky, V.; Limmer, S.; Manoharan, M.; Vornlocher, H. P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature, 2004, 432, 173-178.
378. Song, E.; Zhu, P.; Lee, S. K.; Chowdhury, D.; Kussman, S.; Dykxhoorn, D. M.; Feng, Y.; Palliser, D.; Weiner, D. B.; Shankar, P.; Marasco, W. A.; Lieberman, J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol., 2005, 23, 709-717.
379. Tan, W.; Wang, K.; He, X.; Zhao, X. J.; Drake, T.; Wang, L.; Bagwe, R. P. Bionanotechnology based on silica nanoparticles. Med. Res. Rev., 2004, 24, 621-638.
380. He, X. X.; Wang, K.; Tan, W.; Liu, B.; Lin, X.; He, C.; Li, D.; Huang, S.; Li, J. Bioconjugated nanoparticles for DNA protection from cleavage. J. Am. Chem. Soc., 2003, 125, 7168-7169.
381. Apolonia, L.; Waddington, S. N.; Fernandes, C.; Ward, N. J.; Bouma, G.; Blundell, M. P.; Thrasher, A. J.; Collins, M. K.; Philpott, N. J. Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol. Ther., 2007, 15, 1947-1954.